Announcements Trials
Browse Landscape

Phase

Phase 1 70Phase 2 36Phase 1/2 25Phase 3 21Phase NA 9Phase 4 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 15INDUSTRY 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Thoracic 1

Conditions

Neoplasms 66Breast Neoplasms 64Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 40Neoplasm Metastasis 23Colorectal Neoplasms 21Multiple Myeloma 20Pain 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Anemia 16Keratosis, Actinic 15Lung Neoplasms 14Cancer Pain 14Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 11Leukemia 11Leukemia, Lymphocytic, Chronic, B-Cell 10Carcinoma, Renal Cell 10Carcinoma, Hepatocellular 9Carcinoma 9Neuroendocrine Tumors 8Melanoma 8Lymphoma 8Ovarian Neoplasms 7Leukemia, Myeloid, Acute 7Uterine Cervical Neoplasms 6Recurrence 6Gastrointestinal Stromal Tumors 6Stomatitis 5Stomach Neoplasms 5

Interventions

Nivolumab 2Ipilimumab 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Kidney Neoplasms × Clear all
NCT04513522 2025-07-11

CheckMate 7C9

Bristol-Myers Squibb

Phase 4 Completed
101 enrolled 12 charts
Genitourinary

Kidney Neoplasms

NCT03444766 2020-12-04

Study of Nivolumab for Advanced Cancers in India

Bristol-Myers Squibb

Phase 4 Completed
100 enrolled 12 charts
GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms

NCT01514448 2017-07-19

Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

Novartis

Phase 4 Completed
29 enrolled 9 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡